Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues
about
Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma.Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patientsRevealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds.Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer.Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancerPrediction of anti-angiogenesis escape.Genetic and molecular changes in ovarian cancer.Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations.Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factorsFeasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays.Prognostic biomarkers in endometrial and ovarian carcinoma.Ovarian cancer: diagnostic, biological and prognostic aspects.Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.
P2860
Q30998420-4F23A58A-7B93-4D7D-A5E1-A049E11C9BA7Q35284791-A1951881-0249-437E-BAE2-2E831D7CF6ADQ35593154-0AA8D33B-FADF-427D-B576-D4A988991D48Q35881645-41077ABF-9B52-499E-A815-39FF931BD9D0Q36166893-58D95976-FF00-4B30-B174-C4E16B88519FQ36241387-FD1E250C-8826-46D1-BF54-1E3C7E503442Q36584991-751D0E3F-D91F-4082-89CF-C2E15020D050Q36730777-DBE098A0-AE39-4309-B926-AA1AED046D43Q37094076-7558503F-A9C9-4168-AFDD-3EBB618E7109Q37147652-3AFCD1F0-E59F-4B1E-BDF2-F897D1783EC6Q37237629-22C4FA44-5FC9-4101-8C07-6334B51D7E8DQ37300967-D7215448-DCD0-4ED8-A645-CDE70FF0C908Q38185940-32A8E28B-55AB-4E72-85AC-48BF5F0C72A6Q38261795-13539E01-E092-43AA-8FA9-EC8805A24B16Q46083075-934DD0B7-4E88-48CA-B5FC-929DD6EFD48A
P2860
Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Validation of ovarian cancer g ...... ixed paraffin embedded tissues
@en
Validation of ovarian cancer g ...... xed paraffin embedded tissues.
@nl
type
label
Validation of ovarian cancer g ...... ixed paraffin embedded tissues
@en
Validation of ovarian cancer g ...... xed paraffin embedded tissues.
@nl
prefLabel
Validation of ovarian cancer g ...... ixed paraffin embedded tissues
@en
Validation of ovarian cancer g ...... xed paraffin embedded tissues.
@nl
P2093
P2860
P1433
P1476
Validation of ovarian cancer g ...... ixed paraffin embedded tissues
@en
P2093
Andrew Berchuck
Edwin S Iversen
Gregory P Sfakianos
Jeffrey R Marks
Liudmila Akushevich
Regina Whitaker
Susan K Murphy
P2860
P304
P356
10.1016/J.YGYNO.2012.12.030
P407
P577
2012-12-26T00:00:00Z